Hims & Hers Health (Hims & Hers Health) Risk Assessment

View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Hims & Hers Health is: No Data: Cannot be evaluated.

Competitive Comparison of Hims & Hers Health's Risk Assessment

For the Household & Personal Products subindustry, Hims & Hers Health's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hims & Hers Health's Risk Assessment Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hims & Hers Health's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's Risk Assessment falls into.

Hims & Hers Health (NYSE:HIMS) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Hims & Hers Health Risk Assessment Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

Hims & Hers Health (Hims & Hers Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

82W:Germany

Address

2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123

Website

https://www.forhims.com

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.

Executives

Andrew Dudum	director, 10 percent owner, officer: Chief Executive Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe	officer: Chief Financial Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton	officer: See Remarks	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund	officer: Interim PFO/PAO	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird	officer: Chief Operating Officer	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells	director	C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard	director	2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz	director	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis	director	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi	officer: Chief Marketing Officer	2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash	10 percent owner	3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham	10 percent owner	1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll	officer: Chief Medicall Officer	2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123